Stock listing

NASDAQ:NEOS Neos Therapeutics Inc Stock

Follow Neos Therapeutics Inc into a list and get an email when it puts out news.

Last close · NASDAQ:NEOS

$1.15 USD

Close on Mar 19, 2021 · No longer trades

Jul 22, 2015 to last close -92.3% · weekly closes, Jul 22, 2015 – Mar 19, 2021
Lowest – highest close
$0.466 – $27.09 USDSince Jul 22, 2015 · lowest Oct 16, 2020 · highest Aug 28, 2015

Delisted NASDAQ:NEOS no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:NEOS
Asset type
Stock
Exchange
NASDAQ
Currency
USD

Neos Therapeutics Inc on 6ix

Decks
1 deck · latest Dec 11, 2020

Decks

DeckKindSlidesDate
Merger or Acquisition (December 2020)Merger or acquisition19 slidesDec 11, 2020

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
John Schmid
Other companies: BlossomHill Therapeutics, Inc. (Board Member · Since at least Aug 6, 2026); First Tracks Biotherapeutics, Inc. (Director · Since at least Apr 1, 2026); Helix Acquisition Corp. III (Director · Since at least Jan 22, 2026); Design Therapeutics, Inc. (Director · Since at least Mar 25, 2021); AnaptysBio, Inc. (Director · Since at least Feb 2, 2018); BridgeBio Oncology Therapeutics, Inc. (Director · Feb 8, 2024 – Feb 8, 2024 · Past); Xeris Biopharma Holdings, Inc. (Director · Oct 5, 2021 – Aug 12, 2024 · Past); MoonLake Immunotherapeutics (Director · Oct 19, 2020 – Oct 19, 2020 · Past); Poseida Therapeutics Inc (Director · Jul 9, 2020 – Jan 8, 2025 · Past)
Director · Jul 2, 2018 – Mar 19, 2021 · Past
Paul Edick
Other companies: Vistagen Therapeutics, Inc. (Director · Since at least Oct 27, 2025); Xeris Biopharma Holdings, Inc. (See Remarks, Director · Oct 5, 2021 – Jan 31, 2024 · Past); Milestone Pharmaceuticals Inc. (Director · May 8, 2019 – Jun 5, 2020 · Past); Sucampo Pharmaceuticals Inc (Director · Aug 1, 2016 – Feb 13, 2018 · Past); PDL BioPharma Inc (Director · Sep 3, 2015 – Jun 8, 2018 · Past); Durata Therapeutics Inc (Chief Executive Officer, Director · Mar 15, 2012 – Nov 17, 2014 · Past); Lumos Pharma Inc (Director · Nov 10, 2011 – May 12, 2017 · Past)
Director · Jul 22, 2015 – Jul 3, 2017 · Past
Gerald W McLaughlin
Other companies: Allarity Therapeutics, Inc. (Director · Since at least Oct 1, 2022); Aytu BioPharma, Inc. (Director · Mar 19, 2021 – Apr 8, 2021 · Past); Skye Bioscience, Inc. (Director · Oct 31, 2014 – Oct 20, 2015 · Past); NuPathe Inc. (SVP, Chief Commercial Officer · Aug 5, 2010 – Feb 21, 2014 · Past)
Chief Executive Officer, Director · Jun 27, 2018 – Mar 19, 2021 · Past
James A Robinson Jr
Other companies: Eledon Pharmaceuticals, Inc. (Director · Since at least Oct 1, 2023); UroGen Pharma Ltd. (Director · Since at least Jul 25, 2023); Urovant Sciences Ltd (PEO;CEO/Urovant Sciences, Inc., Director · Mar 1, 2019 – Mar 29, 2021 · Past); Alkermes plc (President & COO,Alkermes, Inc. · Mar 5, 2018 – Apr 4, 2019 · Past)
Director · Jan 29, 2019 – Mar 19, 2021 · Past
Richard I Eisenstadt
Other companies: Altimmune, Inc. (Chief Financial Officer · Dec 31, 2021 – Jan 30, 2024 · Past); Aytu BioPharma, Inc. (Chief Financial Officer · Mar 31, 2021 – Mar 31, 2021 · Past); Ocera Therapeutics Inc (VP, Finance & CFO · Apr 1, 2011 – Aug 7, 2012 · Past)
Chief Financial Officer · Jul 22, 2015 – Mar 19, 2021 · Past
Alan L Heller
Other companies: Savient Pharmaceuticals Inc (Director · May 23, 2006 – Sep 15, 2011 · Past); Northfield Laboratories Inc (Director · Feb 18, 2006 – Jan 2, 2009 · Past)
Director · Jul 22, 2015 – Mar 19, 2021 · Past
Beth Hecht
Other companies: Xeris Biopharma Holdings, Inc. (See Remarks · Since at least Oct 5, 2021); Aytu BioPharma, Inc. (Director · Mar 19, 2021 – Apr 8, 2021 · Past)
Director · Sep 1, 2015 – Mar 19, 2021 · Past
Bryant Fong
Other companies: TruGolf Holdings, Inc. (Director · Oct 26, 2021 – Oct 26, 2021 · Past); ADMA Biologics Inc (Director · Feb 13, 2012 – Feb 26, 2024 · Past)
Director · Jul 22, 2015 – Mar 19, 2021 · Past
Vipin K Garg
Other companies: Altimmune, Inc. (Director · Since at least Nov 30, 2018); Ocera Therapeutics Inc (President & CEO, Director · Apr 1, 2011 – Aug 7, 2012 · Past)
Chief Executive Officer · Jul 22, 2015 – Mar 1, 2018 · Past
John M Limongelli
Other companies: Trevena, Inc. (Sr. VP,General Counsel & CAO · Feb 28, 2018 – Feb 28, 2018 · Past)
SVP & General Counsel · Mar 20, 2019 – Mar 19, 2021 · Past
All 15 people
PersonSeat
Linda Szyper
Other companies: Harmony Biosciences Holdings, Inc. (Director · Since at least Nov 18, 2021)
Director · Apr 27, 2018 – Mar 19, 2021 · Past
Dorothy EngelkingVP, Regulatory Affairs · Jul 22, 2015 – Mar 1, 2018 · Past
Gregory J RobitailleDirector · Jul 22, 2015 – Mar 19, 2021 · Past
Mark TenglerChief Technology Officer · Jul 22, 2015 – Sep 1, 2015 · Past
Thomas P McDonnellChief Commercial Officer · Jul 22, 2015 – May 1, 2018 · Past

Open People

Log in to ask 6ix AI your own questions about Neos Therapeutics Inc.